90.66
price up icon0.98%   0.88
after-market Handel nachbörslich: 90.66
loading

Finanzdaten der Mirum Pharmaceuticals Inc-Aktie (MIRM)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
11.97%
148.93
133.01 127.78 111.58 99.41
Operating Expenses
17.71%
153.50
130.41 132.77 126.77 123.64
Benefits Costs and Expenses
18.05%
153.90
130.37 133.24 125.23 123.78
Costs And Expenses
18.05%
153.90
130.37 133.24 125.23 123.78
Operating Income/Loss
275.45%
-4.567
2.603 -4.989 -15.18 -24.22
Income/Loss From Continuing Operations Before Tax
287.78%
-4.963
2.643 -5.459 -13.65 -24.37
Income Tax Expense/Benefit
392.75%
0.767
-0.262 0.402 1.029 -0.576
Income/Loss From Continuing Operations After Tax
297.25%
-5.73
2.905 -5.861 -14.68 -23.79
Net Income/Loss
297.25%
-5.73
2.905 -5.861 -14.68 -23.79
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
99.13%
0.4402
50.64 49.73 48.89 0.2058
Diluted Average Shares
99.23%
0.4402
56.99 49.73 48.89 0.2058
Basic Earnings Per Share
300.00%
-0.12
0.06 -0.12 -0.30 -0.49
Diluted Earnings Per Share
340.00%
-0.12
0.05 -0.12 -0.30 -0.49
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$45.65
price down icon 0.48%
$28.06
price down icon 1.72%
$52.56
price down icon 1.55%
$91.19
price up icon 1.21%
$139.50
price down icon 0.01%
biotechnology ONC
$284.05
price down icon 0.44%
Kapitalisierung:     |  Volumen (24h):